Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11.21M | $1.09B | 5.60% | +2.29M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 9.77M | $949.0M | 4.88% | -2.54M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 9.56M | $929.0M | 4.77% | +100.0K | 2026-03-31 |
| FMR LLC | 8.46M | $823.0M | 4.23% | -123.7K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.36M | $813.0M | 4.18% | -- | 2026-03-31 |
| Nextech Invest, Ltd. | 7.60M | $739.0M | 3.80% | -- | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.50M | $729.0M | 3.75% | -- | 2026-03-31 |
| Paradigm Biocapital Advisors LP | 6.66M | $647.0M | 3.32% | +11.3K | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 6.03M | $586.0M | 3.01% | -959.8K | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.48M | $532.0M | 2.74% | +3.27M | 2026-03-31 |
